Acute severe ulcerative colitis: confronting an intensified stressor during the COVID-19 pandemic
- PMID: 33545082
- PMCID: PMC7906720
- DOI: 10.1016/S2468-1253(21)00009-1
Acute severe ulcerative colitis: confronting an intensified stressor during the COVID-19 pandemic
Comment on
-
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study.Lancet Gastroenterol Hepatol. 2021 Apr;6(4):271-281. doi: 10.1016/S2468-1253(21)00016-9. Epub 2021 Feb 2. Lancet Gastroenterol Hepatol. 2021. PMID: 33545083 Free PMC article.
References
-
- Singh AK, Jena A, Kumar-M P, Sharma V, Sebastian S. Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis. United European Gastroenterol J. 2020 doi: 10.1177/2050640620972602. published online Nov 19. - DOI - PMC - PubMed
-
- Sebastian S, Walker GJ, Kennedy NA, et al. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Lancet Gastroenterol Hepatol. 2021 doi: 10.1016/S2468-1253(21)00016-9. published online Feb 2. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
